1. Home
  2. FRSH vs KYMR Comparison

FRSH vs KYMR Comparison

Compare FRSH & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FRSH
  • KYMR
  • Stock Information
  • Founded
  • FRSH 2010
  • KYMR 2015
  • Country
  • FRSH United States
  • KYMR United States
  • Employees
  • FRSH N/A
  • KYMR N/A
  • Industry
  • FRSH EDP Services
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • FRSH Technology
  • KYMR Health Care
  • Exchange
  • FRSH Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • FRSH 3.7B
  • KYMR 4.3B
  • IPO Year
  • FRSH 2021
  • KYMR 2020
  • Fundamental
  • Price
  • FRSH $11.47
  • KYMR $55.98
  • Analyst Decision
  • FRSH Buy
  • KYMR Strong Buy
  • Analyst Count
  • FRSH 16
  • KYMR 18
  • Target Price
  • FRSH $19.69
  • KYMR $65.56
  • AVG Volume (30 Days)
  • FRSH 3.3M
  • KYMR 763.3K
  • Earning Date
  • FRSH 11-05-2025
  • KYMR 10-30-2025
  • Dividend Yield
  • FRSH N/A
  • KYMR N/A
  • EPS Growth
  • FRSH N/A
  • KYMR N/A
  • EPS
  • FRSH N/A
  • KYMR N/A
  • Revenue
  • FRSH $782,097,000.00
  • KYMR $44,711,000.00
  • Revenue This Year
  • FRSH $17.02
  • KYMR $60.88
  • Revenue Next Year
  • FRSH $13.01
  • KYMR N/A
  • P/E Ratio
  • FRSH N/A
  • KYMR N/A
  • Revenue Growth
  • FRSH 19.78
  • KYMR N/A
  • 52 Week Low
  • FRSH $10.76
  • KYMR $19.45
  • 52 Week High
  • FRSH $19.77
  • KYMR $63.96
  • Technical
  • Relative Strength Index (RSI)
  • FRSH 44.06
  • KYMR 51.21
  • Support Level
  • FRSH $10.76
  • KYMR $57.32
  • Resistance Level
  • FRSH $11.61
  • KYMR $61.83
  • Average True Range (ATR)
  • FRSH 0.36
  • KYMR 2.80
  • MACD
  • FRSH 0.08
  • KYMR -0.54
  • Stochastic Oscillator
  • FRSH 75.55
  • KYMR 8.17

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: